Egypt's Healthtech 30Med Secures Pre-seed Funding
The funding will help the company develop its platform and expand its reach.
Egypt-based B2B healthtech 30Med has wrapped up an undisclosed pre-seed funding round.[1]
With a focus on bridging the gap between pharmaceutical companies and physicians, 30Med, founded by Doctor Ayman Ragab, utilizes interactive videos and conference events to showcase new medicines and facilitate continuous learning.
This pre-seed funding is set to provide the startup with the resources needed to enhance its platform and expand its reach within the medical community.
30Med boasts a sizable user base of doctors eager to stay updated with the latest advancements in medicine and pharmaceuticals.
30Med's platform enables pharmaceutical companies to present new medicines through interactive videos and conferences.